Journal of Clinical Endocrinology & Metabolism, Vol 81, 4051-4058, Copyright © 1996 by Endocrine Society

ARTICLES

Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting

S Grinspoon, C Corcoran, K Lee, B Burrows, J Hubbard, L Katznelson, M Walsh, A Guccione, J Cannan, H Heller, N Basgoz and A Klibanski
Neuroendocrine Unit, Massachusetts General Hospital, Boston 02114, USA.

The acquired immunodeficiency syndrome (AIDS) wasting syndrome (AWS) is a devastating complication of human immunodeficiency virus infection characterized by a disproportionate decrease in lean body mass. The pathogenesis of the AWS is unknown, but recent data suggest that endogenous secretion of the potent anabolic hormone, testosterone; is decreased in 30-50% of men with AIDS. However, it is unknown whether decreased androgen levels are associated with decreased lean body mass and/or functional decreases in muscle strength and aerobic capacity in hypogonadal men with the AWS. In addition, testosterone is known to have stimulatory effects on GH secretion, and the loss of these effects on the GH-insulin-like growth factor I (IGF-I) axis may be an additional mechanism of decreased lean body mass in this population. Twenty hypogonadal subjects (free-testosterone < 12 pg/mL) with weight loss > 10% of preillness weight or absolute weight < 90% ideal body weight (IBW) were enrolled in the study. None of the subjects were receiving Megace. Lean body mass and fat-free mass were determined by potassium-40 isotope analysis (40K) and dual-energy x-ray absorptiometry, respectively, and analyzed with respect to gonadal function by linear regression analysis. Muscle mass was determined by urinary creatinine excretion, and exercise functional capacity was assessed by a 6-min walk test, a sit-to-stand test, and a timed get-up- and-go test. Results also were compared with gonadal function by regression analysis. IGF-I and mean overnight GH levels, determined from frequent sampling (q20 min from 2000-0800 h), were compared with results obtained from age- and sex-matched normal controls. Subjects were 26-58 yr of age (39 +/- 7 yr, mean +/- SD) with a CD4 cell count of 150 +/- 186 cells/mm3. Serum levels of FSH were elevated in 30% of the subjects. Muscle mass was significantly reduced, compared with expected mass for height (23.3 +/- 5.5 vs. 29.3 +/- 1.7 kg, P = 0.0001) and was decreased disproportionately to weight (77% of expected value for muscle mass vs. 93% of expected value for weight). Free- testosterone levels were correlated with total body potassium (R = 0.45, P < 0.05) and muscle mass (R = 0.45, P < 0.05). Total- testosterone levels were correlated with exercise functional capacity (R = 0.64, P = 0.01 for the sit-to-stand test and R = 0.53, P < 0.05 for the 6-min walk test). Mean GH levels were significantly increased (3.03 +/- 1.76 vs. 0.90 +/- 0.37 ng/mL, P < 0.001) and IGF-I levels decreased (167 +/- 66 vs. 225 +/- 69 ng/mL, P < 0.01), compared with age- and sex-matched eugonadal controls. GH levels were inversely correlated with caloric intake (R = -0.60, P = 0.02) and percent fat mass by dual-energy x-ray absorptiometry (R = 0.58, P = 0.02). Six additional hypogonadal subjects receiving Megace for AIDS wasting were analyzed separately. Nutritional status and parameters of body composition were compared in the Megace and non-Megace-treated subjects. No significant differences in caloric intake, lean body mass, fat mass, or muscle mass were demonstrated. These data demonstrate that changes in body composition, including loss of lean body and muscle mass, and deterioration in exercise functional capacity are highly correlated with androgen levels in hypogonadal men with the AWS. Furthermore, our data demonstrate significantly increased GH levels and decreased IGF-I in association with low weight in this population. These data suggest that androgen deficiency combined with classical GH resistance may contribute to the critical loss of lean body and muscle mass in hypogonadal men with the AWS. These data are the first to link muscle and lean body wasting with progressive gonadal dysfunction among the large percentage of men with AIDS wasting who are hypogonadal. This demonstrates the need for additional studies to determine the efficacy of gonadal steroid replacement to increase lean body mass in this population.

This article has been cited by other articles:

				C. Wang, M. J. Powell, V. M. Popov, and R. G. Pestell Acetylation in Nuclear Receptor Signaling and the Role of Sirtuins Mol. Endocrinol., March 1, 2008; 22(3): 539 - 545. [Abstract] [Full Text] [PDF]

				E. Aghdassi, B. Arendt, I. E. Salit, and J. P. Allard Estimation of Body Fat Mass Using Dual-Energy X-Ray Absorptiometry, Bioelectric Impedance Analysis, and Anthropometry in HIV-Positive Male Subjects Receiving Highly Active Antiretroviral Therapy JPEN J Parenter Enteral Nutr, March 1, 2007; 31(2): 135 - 141. [Abstract] [Full Text] [PDF]

				W. J. Evans Megestrol Acetate Use for Weight Gain Should Be Carefully Considered J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 420 - 421. [Full Text] [PDF]

				M. Fu, M. Liu, A. A. Sauve, X. Jiao, X. Zhang, X. Wu, M. J. Powell, T. Yang, W. Gu, M. L. Avantaggiati, et al. Hormonal Control of Androgen Receptor Function through SIRT1 Mol. Cell. Biol., November 1, 2006; 26(21): 8122 - 8135. [Abstract] [Full Text] [PDF]

				S. Bhasin, G. R. Cunningham, F. J. Hayes, A. M. Matsumoto, P. J. Snyder, R. S. Swerdloff, and V. M. Montori Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 1995 - 2010. [Abstract] [Full Text] [PDF]

				S. Johnsen, S. E. Dolan, K. V. Fitch, K. M. Killilea, J. L. Shifren, and S. K. Grinspoon Absence of Polycystic Ovary Syndrome Features in Human Immunodeficiency Virus-Infected Women Despite Significant Hyperinsulinemia and Truncal Adiposity J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5596 - 5604. [Abstract] [Full Text] [PDF]

				C. Cuerda, A. Zugasti, I. Breton, M. Camblor, P. Miralles, and P. Garcia Treatment With Nandrolone Decanoate and Megestrol Acetate in HIV-Infected Men Nutr Clin Pract, February 1, 2005; 20(1): 93 - 97. [Abstract] [Full Text] [PDF]

				E. T. Schroeder, L. Zheng, M. D. Ong, C. Martinez, C. Flores, Y. Stewart, C. Azen, and F. R. Sattler Effects of Androgen Therapy on Adipose Tissue and Metabolism in Older Men J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4863 - 4872. [Abstract] [Full Text] [PDF]

				R. Roubenoff, S. Grinspoon, P. R. Skolnik, E. Tchetgen, L. Abad, D. Spiegelman, T. Knox, and S. Gorbach Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E138 - E145. [Abstract] [Full Text] [PDF]

				S. Grinspoon and M. Gelato Editorial: The Rational Use of Growth Hormone in HIV-Infected Patients J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3478 - 3479. [Full Text] [PDF]

				J. C. Lo and M. Schambelan Reproductive Function in Human Immunodeficiency Virus Infection J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2338 - 2343. [Full Text] [PDF]

				P. Rietschel, C. Hadigan, C. Corcoran, T. Stanley, G. Neubauer, J. Gertner, and S. Grinspoon Assessment of Growth Hormone Dynamics in Human Immunodeficiency Virus-Related Lipodystrophy J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 504 - 510. [Abstract] [Full Text]

				D. P. Kotler Cachexia Ann Intern Med, October 17, 2000; 133(8): 622 - 634. [Abstract] [Full Text] [PDF]

				C. Corcoran, E. J Anderson, B. Burrows, T. Stanley, M. Walsh, A. M Poulos, and S. Grinspoon Comparison of total body potassium with other techniques for measuring lean body mass in men and women with AIDS wasting Am. J. Clinical Nutrition, October 1, 2000; 72(4): 1053 - 1058. [Abstract] [Full Text] [PDF]

				M. Javanbakht, A. B. Singh, N. A. Mazer, G. Beall, I. Sinha-Hikim, R. Shen, and S. Bhasin Pharmacokinetics of a Novel Testosterone Matrix Transdermal System in Healthy, Premenopausal Women and Women Infected with the Human Immunodeficiency Virus J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2395 - 2401. [Abstract] [Full Text]

				S. Bhasin, T. W. Storer, M. Javanbakht, N. Berman, K. E. Yarasheski, J. Phillips, M. Dike, I. Sinha-Hikim, R. Shen, R. D. Hays, et al. Testosterone Replacement and Resistance Exercise in HIV-Infected Men With Weight Loss and Low Testosterone Levels JAMA, February 9, 2000; 283(6): 763 - 770. [Abstract] [Full Text] [PDF]

				C. Hadigan, C. Corcoran, T. Stanley, S. Piecuch, A. Klibanski, and S. Grinspoon Fasting Hyperinsulinemia in Human Immunodeficiency Virus-Infected Men: Relationship to Body Composition, Gonadal Function, and Protease Inhibitor Use J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 35 - 41. [Abstract] [Full Text]

				S. Grinspoon, C. Corcoran, T. Stanley, A. Baaj, N. Basgoz, and A. Klibanski Effects of Hypogonadism and Testosterone Administration on Depression Indices in HIV-Infected Men J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 60 - 65. [Abstract] [Full Text]

				T. DOUCHI, S. YAMAMOTO, T. OKI, K. MARUTA, R. KUWAHATA, and Y. NAGATA Serum Androgen Levels and Muscle Mass in Women With Polycystic Ovary Syndrome Obstet. Gynecol., September 1, 1999; 94(3): 337 - 340. [Abstract] [Full Text] [PDF]

				M. Sheffield-Moore, R. J. Urban, S. E. Wolf, J. Jiang, D. H. Catlin, D. N. Herndon, R. R. Wolfe, and A. A. Ferrando Short-Term Oxandrolone Administration Stimulates Net Muscle Protein Synthesis in Young Men J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2705 - 2711. [Abstract] [Full Text]

				C. Corcoran and S. Grinspoon Treatments for Wasting in Patients with the Acquired Immunodeficiency Syndrome N. Engl. J. Med., June 3, 1999; 340(22): 1740 - 1750. [Full Text] [PDF]

				F. R. Sattler, S. V. Jaque, E. T. Schroeder, C. Olson, M. P. Dube, C. Martinez, W. Briggs, R. Horton, and S. Azen Effects of Pharmacological Doses of Nandrolone Decanoate and Progressive Resistance Training in Immunodeficient Patients Infected with Human Immunodeficiency Virus J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1268 - 1276. [Abstract] [Full Text]

				The Use of Testosterone in the AIDS Wasting Syndrome AIDS Clinical Care, April 1, 1999; 1999(401): 1 - 1. [Full Text]

				D. P Kotler, D. M Thea, M. Heo, D. B Allison, E. S Engelson, J. Wang, R. N Pierson Jr, M. S. Louis, and G. T Keusch Relative influences of sex, race, environment, and HIV infection on body composition in adults Am. J. Clinical Nutrition, March 1, 1999; 69(3): 432 - 439. [Abstract] [Full Text] [PDF]

				S. Grinspoon, C. Corcoran, D. Rosenthal, T. Stanley, K. Parlman, M. Costello, M. Treat, S. Davis, B. Burrows, N. Basgoz, et al. Quantitative Assessment of Cross-Sectional Muscle Area, Functional Status, and Muscle Strength in Men with the Acquired Immunodeficiency Syndrome Wasting Syndrome J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 201 - 206. [Abstract] [Full Text]

				B. R. Bistrian Dietary Treatment in Secondary Wasting and Cachexia J. Nutr., January 1, 1999; 129(1): 290S - 290S. [Full Text] [PDF]

				S. Grinspoon, C. Corcoran, T. Stanley, L. Katznelson, and A. Klibanski Effects of Androgen Administration on the Growth Hormone-Insulin-Like Growth Factor I Axis in Men with Acquired Immunodeficiency Syndrome Wasting J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4251 - 4256. [Abstract] [Full Text]

				S. Bhasin, T. W. Storer, N. Asbel-Sethi, A. Kilbourne, R. Hays, I. Sinha-Hikim, R. Shen, S. Arver, and G. Beall Effects of Testosterone Replacement with a Nongenital, Transdermal System, Androderm, in Human Immunodeficiency Virus-Infected Men with Low Testosterone Levels J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3155 - 3162. [Abstract] [Full Text]

				S. E. Mulroney, K. J. McDonnell, C. B. Pert, M. R. Ruff, Z. Resch, W. K. Samson, and M. D. Lumpkin HIV gp120 inhibits the somatotropic axis: A possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting PNAS, February 17, 1998; 95(4): 1927 - 1932. [Abstract] [Full Text] [PDF]

				S. Grinspoon, C. Corcoran, K. Miller, B. M. K. Biller, H. Askari, E. Wang, J. Hubbard, E. J. Anderson, N. Basgoz, H. M. Heller, et al. Body Composition and Endocrine Function in Women with Acquired Immunodeficiency Syndrome Wasting J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1332 - 1337. [Abstract] [Full Text] [PDF]